Volume 19, Issue 2, March/April 2022
Cover Story
04/18/2022
With the ever-rising costs of medications, new business models and patient care initiatives are becoming increasingly common methods to disrupt the industry to instill lasting change. But how do these recent ventures, like Mark Cuban’s new...
With the ever-rising costs of medications, new business models and patient care initiatives are becoming increasingly common methods to disrupt the industry to instill lasting change. But how do these recent ventures, like Mark Cuban’s new...
With the ever-rising costs of...
04/18/2022
First Report Managed Care
Department
Interview
04/18/2022
In this interview, Robert Gibbons, PhD, discusses his work to advance mental health research and utilize the computerized adaptive test suicide scale for the United States veteran population.
In this interview, Robert Gibbons, PhD, discusses his work to advance mental health research and utilize the computerized adaptive test suicide scale for the United States veteran population.
In this interview, Robert...
04/18/2022
First Report Managed Care
Conference Insider
03/15/2022
According to a recent presentation at the 2022 American Academy of Allergy, Asthma, & Immunology Annual Meeting, replication-incompetent adenovirus and mRNA vaccines against COVID-19 are tolerated among patients with confirmed or suspected...
According to a recent presentation at the 2022 American Academy of Allergy, Asthma, & Immunology Annual Meeting, replication-incompetent adenovirus and mRNA vaccines against COVID-19 are tolerated among patients with confirmed or suspected...
According to a recent...
03/15/2022
First Report Managed Care
Conference Insider
03/15/2022
Compared to healthy adults, patients with severe asthma or atopic dermatitis on biologic therapies have lower antibody levels after SARS-CoV-2 mRNA vaccination, according to study findings presented at the 2022 American Academy of Allergy,...
Compared to healthy adults, patients with severe asthma or atopic dermatitis on biologic therapies have lower antibody levels after SARS-CoV-2 mRNA vaccination, according to study findings presented at the 2022 American Academy of Allergy,...
Compared to healthy adults,...
03/15/2022
First Report Managed Care
Conference Insider
03/15/2022
“The results from this study are encouraging, indicating that an epinephrine treatment alternative, which can be administered sublingually for cases of life-threatening allergic reactions, has the potential to meet the therapeutic window...
“The results from this study are encouraging, indicating that an epinephrine treatment alternative, which can be administered sublingually for cases of life-threatening allergic reactions, has the potential to meet the therapeutic window...
“The results from this study are...
03/15/2022
First Report Managed Care
Feature
Feature
04/18/2022
With hospitals and health care systems already under constant pressure to be adequately prepared for natural disasters and other emergencies, refining risk assessments and a network of partners with clear communication actively in place has...
With hospitals and health care systems already under constant pressure to be adequately prepared for natural disasters and other emergencies, refining risk assessments and a network of partners with clear communication actively in place has...
With hospitals and health care...
04/18/2022
First Report Managed Care
Feature
04/18/2022
The official end to the public health emergency is a welcome sight for most, but for Medicaid enrollees, it could signal disruption as the coverage redetermination process is restored. How will states react, what measures can help the...
The official end to the public health emergency is a welcome sight for most, but for Medicaid enrollees, it could signal disruption as the coverage redetermination process is restored. How will states react, what measures can help the...
The official end to the public...
04/18/2022
First Report Managed Care
